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A Newly Developed B Cell Immunoglobulin 
Phenotyping Panel to Facilitate More Efficient 
HIV-1 Antibody Discovery
Leonard Nettey 1, Thomas Liechti 1, Mario Roederer 1, Rosemarie Mason 1
1Vaccine Research Center (VRC), National Institute of Allergy and 
Infectious Disease (NIAID), National Institutes of Health (NIH), 
United States
Background: Antibody discovery research has been instrumental in 
facilitating the isolation and characterization of HIV-specific broadly 
neutralizing antibodies. With growing interest in mining the antibody 
repertoire in order to identify additional HIV-specific antibodies and 
characterize their multiple effector functions, there is a clear need to 
capture antibody subclass information at the single cell level.
Methods: We tested over 100 antibody reagents to design and 
optimize a flow cytometry panel that could characterize the 
phenotypic diversity of circulating HIV-specific memory B cells 
with an emphasis on discriminating immunoglobulin classes and 
subclasses.
Results: Pan-IgA-, pan-IgG-, IgD-, IgM- and IgE-specific antibodies 
were included to define immunoglobulin isotypes of individual B 
cells while IgA and IgG subclasses were delineated using IgA1-, 
IgA2-, IgG1-, IgG2-, IgG3- and IgG4-specific antibodies. We verified 
that immunoglobulin isotypes are exclusively expressed, that each 
subclass within the IgA and IgG isotypes is exclusively expressed and 
that all isotype cells are accounted for by the sum of the subclasses 
(e.g. IgA1 + IgA2 = IgA; IgG1 + IgG2 + IgG3 + IgG4 = IgG). The latter 
validation measure allows anti-pan-IgA and anti-pan-IgG antibodies 
to be removed and substituted with fluorescently labeled HIV-1 
peptide or protein antigens, thus linking antigen-specificity of each 
individual B cell with its immunoglobulin subclass. More importantly, 
combining this newly developed panel with indexed single cell sorting 
methods for HIV antibody discovery (such as antigen-specific single 
B cell sorting and unbiased single B cell culture) will facilitate studies 
to thoroughly interrogate HIV-specific B cell effector functions.
Conclusions: The ability to characterize both epitope specificity 
and IgA/IgG subclass profile at the single B cell level will enable a 
better understanding of the link between HIV-1 antibody specificities, 
effector functions and protective efficacy against HIV-1 infection. 
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A Co-receptor-mimicking Antibody Stabilizes the 
Displaced V1V2 Loops in a Partially Open sCD4-
bound HIV-1 Envelope Complex
Christopher Barnes 1, Haoqing Wang 1, Zhi Yang 1, Michel Nussenzweig 2,3, 
Pamela Bjorkman 1
1California Institute of Technology, United States, 2Rockefeller 
University, United States, 3Howard Hughes Medical Institute, United 
States
Background: HIV-1 envelope glycoprotein (Env), a trimer of gp120-
gp41 heterodimers, mediates membrane fusion after binding host 
receptor CD4. Receptor binding to closed Env displaces the V1V2 
loops from Env‘s apex, allowing co-receptor binding and opening 
Env to enable gp41-mediated fusion.
Methods: Using single-particle cryoEM methods, we solved the 
sCD4-bound structure of a clade B B41 SOSIP trimer in complex with 
21c, a CD4-induced (CD4i) coreceptor-mimicking antibody, and with 
8ANC195, a broadly neutralizing antibody (bNAb) that recognizes the 
gp120-gp41 interface, to a resolution of 4.05 Å.
Results: Despite binding of the 8ANC195 Fab that partially closes 
the open, sCD4-bound Env conformation, our structure shows 
rearrangements in gp120, including displacement of V1V2, exposure 
of V3, formation of the 4-stranded bridging sheet, and formation of 
the α0 helix. In addition, unlike the V1V2 regions in similar sCD4-
bound Env structures complexed with the CD4i antibody 17b, the 
displaced V1V2 loops in the B41-sCD4-21c-8ANC195 structure 
exhibited ordered density allowing the structure of the displaced 
V1V2 to be determined for the first time. Comparing partially- and 
fully-open Envs with closed Envs shows that gp41 rearrangements 
are independent of CD4-induced gp120 bridging sheet formation and 
V1V2 displacement, suggesting an order of conformational changes 
before co-receptor binding: (i) gp120 opening inducing side chain 
rearrangements and a compact gp41 central helix conformation, and 
(ii) bridging sheet formation, and V1V2 displacement.
Conclusions: Analyses of these results further our understanding 
of HIV-1 Env conformational changes leading to fusion and provide 
templates for designing agents to disrupt HIV-1 entry into target cells. 
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